Last Price$20.72.1%
Market Cap$972.8M
46.6%
Industry median - 65.7%
5Y Historical average - 34.4%
(19,314.1%)
Industry median - (855.0%)
5Y Historical average - (18,111.3%)
(15,574.8%)
Industry median - (726.1%)
5Y Historical average - (15,119.0%)
80.4%
Industry median - 83.3%
5Y Historical average - 166.9%
ELVN Profitability Rating
ELVN Profitability rating
5.8
ELVN Profitability rating performance
ELVN Profitability Metrics
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Competing with ELVN Profitability
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Profitability rating | Gross Profit margin (LTM) | EBIT margin (LTM) | EBITDA margin (LTM) | Net Income margin (LTM) | FCF margin (LTM) | Earnings quality (FCF to Net Income) |
$972.8M | 5.8 | 46.6% | (22,815.2%) | (22,743.6%) | (19,366.8%) | (15,574.8%) | 80.4% | |
$124.8B | 6.8 | 86.1% | (2.2%) | 4.4% | (4.9%) | (7.2%) | 147.6% | |
$77.0B | 8.1 | 84.5% | 28.3% | 33.9% | 31.1% | 25.3% | 81.5% | |
$34.4B | 5.9 | 86.8% | (17.1%) | (2.1%) | (4.5%) | (9.4%) | 103.2% | |
$30.7B | 5.3 | 85.6% | (7.9%) | (8.6%) | (12.4%) | (1.9%) | 15.3% | |
$24.0B | 6.3 | 80.3% | (47.8%) | (13.2%) | (24.2%) | (8.4%) | 33.9% | |
$14.5B | 8.4 | 73.9% | 57.1% | 81.0% | 37.9% | 122.3% | 208.1% | |
$13.8B | 9.1 | 89.2% | 47.9% | 55.9% | 41.5% | 37.6% | 90.4% | |
$13.4B | 8.8 | 78.6% | 16.2% | 22.8% | 15.0% | 16.7% | 111.4% | |
$13.3B | 5.7 | N/A | N/A | N/A | N/A | N/A | 64.2% | |
$1,846.9M | 5.8 | 83.7% | (26.3%) | (22.0%) | (95.0%) | (31.4%) | 121.0% |
FAQ
What is the Enliven Therapeutics, Inc. (ELVN) gross profit margin?
The Enliven Therapeutics, Inc. (ELVN) gross profit margin is 46.6%, compared to the industry median of 65.7% and the 5-year historical average of 34.4%.
What is the Enliven Therapeutics, Inc. (ELVN) operating income margin?
The Enliven Therapeutics, Inc. (ELVN) operating income margin is (19,314.1%), compared to the industry median of (855.0%)) and the 5-year historical average of (18,111.3%).
What is the Enliven Therapeutics, Inc. (ELVN) Free Cash Flow (FCF) margin?
The Enliven Therapeutics, Inc. (ELVN) Free Cash Flow margin is (15,574.8%), compared to the industry median of (726.1%) and the 5-year historical average of (15,119.0%).
What is the Enliven Therapeutics, Inc. (ELVN) earnings quality?
The Enliven Therapeutics, Inc. (ELVN) earnings quality is 80.4%, compared to the industry median of 83.3% and the 5-year historical average of 166.9%.